188 related articles for article (PubMed ID: 38212490)
1. Menopausal hormone therapy and risk of sarcoidosis: a population-based nested case-control study in Sweden.
Dehara M; Kullberg S; Bixo M; Sachs MC; Grunewald J; Arkema EV
Eur J Epidemiol; 2024 Mar; 39(3):313-322. PubMed ID: 38212490
[TBL] [Abstract][Full Text] [Related]
2. Menopausal hormone therapy and cancer risk: An overestimated risk?
Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
[TBL] [Abstract][Full Text] [Related]
3. Reproductive and hormonal risk factors for sarcoidosis: a nested case-control study.
Dehara M; Sachs MC; Kullberg S; Grunewald J; Blomberg A; Arkema EV
BMC Pulm Med; 2022 Jan; 22(1):43. PubMed ID: 35073900
[TBL] [Abstract][Full Text] [Related]
4. Prediagnostic use of estrogen-only therapy is associated with improved colorectal cancer survival in menopausal women: a Swedish population-based cohort study.
Simin J; Liu Q; Wang X; Fall K; Williams C; Callens S; Engstrand L; Brusselaers N
Acta Oncol; 2021 Jul; 60(7):881-887. PubMed ID: 33861686
[TBL] [Abstract][Full Text] [Related]
5. Menopausal hormone therapy and biliary tract cancer: a population-based matched cohort study in Sweden.
Kilander C; Lagergren J; Konings P; Sadr-Azodi O; Brusselaers N
Acta Oncol; 2019 Mar; 58(3):290-295. PubMed ID: 30656997
[TBL] [Abstract][Full Text] [Related]
6. Menopausal hormone therapy and risk of incident hypertension: role of the route of estrogen administration and progestogens in the E3N cohort.
Madika AL; MacDonald CJ; Fournier A; Mounier-Vehier C; Béraud G; Boutron-Ruault MC
Menopause; 2021 Sep; 28(11):1204-1208. PubMed ID: 34581294
[TBL] [Abstract][Full Text] [Related]
7. Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.
DeBono NL; Robinson WR; Lund JL; Tse CK; Moorman PG; Olshan AF; Troester MA
J Womens Health (Larchmt); 2018 Mar; 27(3):377-386. PubMed ID: 28570827
[TBL] [Abstract][Full Text] [Related]
8. Is breast cancer risk the same for all progestogens?
Stute P
Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
[TBL] [Abstract][Full Text] [Related]
9. Menopausal hormone therapy and the risk of esophageal and gastric cancer.
Brusselaers N; Maret-Ouda J; Konings P; El-Serag HB; Lagergren J
Int J Cancer; 2017 Apr; 140(7):1693-1699. PubMed ID: 28006838
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary embolism in menopausal hormone therapy: a population-based register study.
Sundell M; Spetz Holm AC; Fredrikson M; Hammar M; Hoffmann M; Brynhildsen J
Climacteric; 2022 Dec; 25(6):615-621. PubMed ID: 36218141
[TBL] [Abstract][Full Text] [Related]
11. Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
Bergendal A; Kieler H; Sundström A; Hirschberg AL; Kocoska-Maras L
Menopause; 2016 Jun; 23(6):593-9. PubMed ID: 27023862
[TBL] [Abstract][Full Text] [Related]
12. Are infectious diseases risk factors for sarcoidosis or a result of reverse causation? Findings from a population-based nested case-control study.
Rossides M; Kullberg S; Askling J; Eklund A; Grunewald J; Di Giuseppe D; Arkema EV
Eur J Epidemiol; 2020 Nov; 35(11):1087-1097. PubMed ID: 32048110
[TBL] [Abstract][Full Text] [Related]
13. Menopausal Hormone Therapy Is Associated With Increased Risk of Fecal Incontinence in Women After Menopause.
Staller K; Townsend MK; Khalili H; Mehta R; Grodstein F; Whitehead WE; Matthews CA; Kuo B; Chan AT
Gastroenterology; 2017 Jun; 152(8):1915-1921.e1. PubMed ID: 28209529
[TBL] [Abstract][Full Text] [Related]
14. Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?
Fournier A; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F
J Clin Oncol; 2009 Nov; 27(31):5138-43. PubMed ID: 19752341
[TBL] [Abstract][Full Text] [Related]
15. Insufficient use of menopausal hormone therapy in Swedish women with early or premature menopause caused by bilateral oophorectomy: a register-based study.
Sundell M; Brynhildsen J; Fredrikson M; Hoffmann M; Spetz Holm AC
BJOG; 2024 Mar; 131(4):500-507. PubMed ID: 37667667
[TBL] [Abstract][Full Text] [Related]
16. Menopausal hormone therapies and risk of colorectal cancer: a Swedish matched-cohort study.
Liu Q; Simin J; Debelius J; Fall K; Sadr-Azodi O; Engstrand L; Williams C; Brusselaers N
Aliment Pharmacol Ther; 2021 Jun; 53(11):1216-1225. PubMed ID: 33857339
[TBL] [Abstract][Full Text] [Related]
17. Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma.
Hassan MM; Botrus G; Abdel-Wahab R; Wolff RA; Li D; Tweardy D; Phan AT; Hawk E; Javle M; Lee JS; Torres HA; Rashid A; Lenzi R; Hassabo HM; Abaza Y; Shalaby AS; Lacin S; Morris J; Patt YZ; Amos CI; Khaderi SA; Goss JA; Jalal PK; Kaseb AO
Clin Gastroenterol Hepatol; 2017 Nov; 15(11):1791-1799. PubMed ID: 28579181
[TBL] [Abstract][Full Text] [Related]
18. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
Davey DA
Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
[TBL] [Abstract][Full Text] [Related]
19. Menopausal hormone therapy and the risk of type 2 diabetes mellitus: Health Insurance Database in South Korea-based retrospective cohort study.
Yuk JS; Kim JM
Menopause; 2023 May; 30(5):497-505. PubMed ID: 36917757
[TBL] [Abstract][Full Text] [Related]
20. Trends in the incidence, prevalence and sales volume of menopausal hormone therapy in Sweden from 2000 to 2021.
Sundell M; Brynhildsen J; Spetz Holm AC; Fredrikson M; Hoffmann M
Maturitas; 2023 Sep; 175():107787. PubMed ID: 37354643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
